Skip to main content
Premium Trial:

Request an Annual Quote

Ambion Licenses siRNA Patent Application from City of Hope Medical Center

NEW YORK, July 22 - Ambion, of Austin, Texas, has exclusively licensed short interfering RNA technology described in a patent application from the City of Hope National Medical Center and Beckman Research Institute, the company said today.


The application stems from an invention by John  Rossi, chair of the division of Molecular Biology at City of Hope Comprehensive Cancer Center. It covers technologies for expressing siRNA from PCR products, the company said. This technology is designed for quick preparation of siRNA expression cassettes without cloning or sequencing.


The company, which sells a variety of siRNA-related products to the research market, did not disclose the financial terms of the licensing deal.



The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.